Volume 2, Number 1 (January/February 2004)

Bench to Bedside

21

  

A Biological Approach to Mucositis
Stephen T. Sonis, DMD, DMSc

Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard School of Dental Medicine, Boston, Massachusetts

With peer viewpoints by Mark M. Schubert, DDS, MSD, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington; Edward B. Rubenstein, MD, The University of Texas M. D. Anderson Cancer Center, Houston Texas, and Jane M. Fall-Dickson, RN, PhD, Bethesda, Maryland

abstract full text 523 kb

39

  

Erythropoietic Agents in the Management of Cancer Patients: Part 2. Studies on Their Role in Neuroprotection and Neurotherapy
Robert E. Smith, Jr., MD

South Carolina Cancer Center and South Carolina Oncology Associates, Columbia, South Carolina

With peer viewpoints by Giovanni Grasso, MD, PhD, University of Messina School of Medicine, Messina, Italy; Michael Brines, MD, PhD, The Kenneth S. Warren Institute, Kitchawan, New York; and Kerry Cheong, BMBS, Kathryn Chrystal, FRACP, and Peter Harper, MD, Guy’s Hospital, London, United Kingdom

abstract full text 110 kb

65

  

Managing Hematologic Toxicities
Gerardo Capo, MD, and Roger Waltzman, MD

St. Vincent’s Comprehensive Cancer Center, New York, New York

With peer viewpoints by A. Robert Turner, MD, FRCPC, University of Alberta Cross Cancer Institute, Edmonton, Alberta, Canada, and Howard Ozer, MD, PhD, and Shubham Pant, MD, Oklahoma University Cancer Center and Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma

abstract full text 129 kb

Original Research

50

  

Pilot Evaluation of Mirtazapine for the Treatment of Hot Flashes
Domingo G. Perez, MD, Charles L. Loprinzi, MD, Debra L. Barton, PhD, Barbara A. Pockaj, MD, Jeff Sloan, PhD, Paul J. Novotny, MS, and Bradley J. Christensen

Mayo Clinic, Rochester, Minnesota, and Mayo Clinic Scottsdale, Scottsdale, Arizona

abstract full text 83 kb

How We Say It

14

  

Shared Uncertainty
Lidia Schapira, MD

Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts

full text 38 kb

Commentary

80

  

Advances in Palliative Surgery for Cancer Patients
Robert S. Krouse, MD

Southern Arizona Veterans Affairs Health Care System, University of Arizona, and Arizona Cancer Center, Tucson, Arizona

full text 82 kb

How We Do It

90

  

How to Initiate and Monitor Infusional Lidocaine for Severe and/or Neuropathic Pain
Rebecca Ferrini, MD, MPH, CMD, and Judith A. Paice, PhD, RN

Edgemoor Hospital, Santee, California and Feinberg School of Medicine, Northwestern University, Chicago, Illinois

full text 68 kb

Clinical Trials

95

  

Clinical Trials in Supportive Care
Current clinical trials in the management of cancer treatment-related mucositis.

full text 55 kb

Observations

18

  

Tetrodotoxin Is Safe and Effective for Severe, Refractory Cancer Pain

full text 27 kb

56

  

Results of THRIVE Treatment Study Show That Ximelagatran Is Safe and Effective Against Thrombosis

full text 26 kb

Reader Services

4

  

Guide for Authors

© 2004 by BioLink Communictions, Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.